antimicrobial resistance (amr) - genomic options to advance canada’s action plan david bailey,...

23
Antimicrobial Resistance (AMR) - Genomic Options to Advance Canada’s Action Plan David Bailey, Ph.D. President and CEO Genome Alberta Beef Value Chain Roundtable (BVCRT) Ottawa, Ontario 4-5 March 2015

Upload: christopher-lane

Post on 14-Dec-2015

225 views

Category:

Documents


1 download

TRANSCRIPT

Antimicrobial Resistance (AMR) -Genomic Options to Advance Canada’s Action Plan

David Bailey, Ph.D.

President and CEOGenome Alberta

Beef Value Chain Roundtable (BVCRT)Ottawa, Ontario4-5 March 2015

Beef Value Chain Roundtable (Ottawa, Ontario)

2

No Antimicrobials – What Would That Mean?

“If antibiotics stopped working, we would find that instead of 7% of deaths being related to infection at the moment in the developed world, it would go back up to about half (50%) of deaths, just because we couldn’t use antibiotics.” ~ Dame Sally Davies, UK Chief Medical Officer (Feb 2015)

“In a world with few effective antibiotics, modern medical advances such as surgery, transplants, and chemotherapy may no longer be viable due to the threat of infection” ~ (USA) National Strategy for Combating Antibiotic-Resistant Bacteria (Sep 2014)

4-5 March 2015

Beef Value Chain Roundtable (Ottawa, Ontario)

3

Outline

Overview - Antimicrobial Resistance (AMR)

Canada’s AMR Action Plan - Key Focus Areas

Genomic Options

Closing Remarks

4-5 March 2015

Beef Value Chain Roundtable (Ottawa, Ontario)

4

Overview - AMR

What is Antimicrobial Resistance?

Resistance of a microbe (bacteria, fungi, viruses, parasites) to an

antimicrobial drug that was originally effective for treatment of

infections caused by it.

~ WHO Fact Sheet No. 194 (2014)

4-5 March 2015

The Economist (31-MAR-2011)

Beef Value Chain Roundtable (Ottawa, Ontario)

5

Overview - AMR

Is Resistance A Natural Phenomenon?

YES - Evolution of resistant

strains is a natural

phenomenon but the use

and misuse of antimicrobial

drugs accelerates the

emergence of drug-resistant

strains.

~ WHO Fact Sheet No. 194 (2014)

4-5 March 2015

~ S

chm

iede

r an

d E

dwar

ds (

2012

)

“There has been a seven-fold increase in the incidence of Vancomycin-resistant Enterococci infections between 2007-2012.”– AMR and Use in Canada (Oct 2014)

Beef Value Chain Roundtable (Ottawa, Ontario)

6

“Resistome”

The collection of all genes that directly

or indirectly contribute to antibiotic

resistance.

Categories

(1) Inactivation (of genes) bacteria

more resistant to antibiotics

(2) Inactivation (of genes) bacteria

more susceptible to antibiotics

Overview - AMR

How Does Resistance Develop?

4-5 March 2015

Resistance Mechanisms

1. Produce enzyme that degrades antibiotic (= antibiotic inactivation)

2. Produce enzyme that alters antibiotic (= target site alteration)

3. Overproduce antibiotic targets (= target amplification)

4. Reduce intracellular accumulation of antibiotic ( influx, efflux)

… option to improve efficacy of current drugs

Beef Value Chain Roundtable (Ottawa, Ontario)

7

(1) VERTICAL

Natural resistance OR Spontaneous mutation

(2) HORIZONTAL

Horizontal transfer of AMR genes to same or different microbes

Overview - AMR

How is Antimicrobial Resistance Transferred?

4-5 March 2015

Bacteria have a new generation

every 20 minutes!~ Dame Sally Davies

2015

AMR AMR

Mobile Genetic Elements

Beef Value Chain Roundtable (Ottawa, Ontario)

8

Overview - AMR

Why is AMR a Global Health Concern?

The rate at which

microbes are acquiring

resistance is GREATER

than the rate at which

antimicrobials are being

discovered.

4-5 March 2015

-- Antimicrobial Resistance – Global Report on Surveillance (World Health Organization, 2014)

“bacteria do not recognize borders”– National (USA) Strategy for Combating Antibiotic-Resistant Bacteria (Sep 2014)

Beef Value Chain Roundtable (Ottawa, Ontario)

9

Overview - AMR

Link between AMR in Humans and Livestock?

“Substantial evidence demonstrates that

use of antibiotics in animal agriculture

promotes the development of antibiotic-

resistant microbes in animals and that

retail meat can be a source of microbes,

including antibiotic-resistant microbes” ~

Report to the (USA) President on Combating Antibiotic Resistance

(Sep 2014)

Transfer of resistant microbes between

humans and livestock does occur

(genomics is helping to prove this point)

4-5 March 2015

“Worldwide, over 70% of all antibiotics prescribed are used on farm animals”

~ Dame Sally Davies 2015

“Up to half of antibiotic use in humans and much of antibiotic use in animals is unnecessary and inappropriate and makes everyone less safe.” ~ CDC 2013

Beef Value Chain Roundtable (Ottawa, Ontario)

10

Canada’s AMR Action Plan - Key Focus Areas

A Federal Framework For Action

4-5 March 2015

SURVEILLANCE

Detecting and monitoring trends and threats in order to

inform strategies to reduce the risks and impacts of

antimicrobial resistance (CNISP, CIPARS, CARSS)

STEWARDSHIP

Conserving the effectiveness of existing treatments

through infection prevention and control guidelines,

education and awareness, regulations, and oversight.

INNOVATION

Creating new solutions to counteract loss in antimicrobial

effectiveness through research and development.

Beef Value Chain Roundtable (Ottawa, Ontario)

11

Genomic Options

Gene? Genome? Genomics?

4-5 March 2015

Gene is the basic physical and functional unit of heredity. Genes,

which are made up of DNA, act as instructions to make molecules

called proteins.

Genome is the complete set of genes or genetic material in a cell or

organism.

Genomics is the study of the structure, content, and evolution of

genomes, and includes analysis of the expression and function of

both genes and proteins.

Epigenetics relates to, or arises from, non-genetic influences on gene

expression.

Beef Value Chain Roundtable (Ottawa, Ontario)

12

Targeted manipulation of gut microbiome to promote growth Probiotics inhibit pathogens by competing for colonization sites

or nutritional sources

Prebiotics selectively stimulate activity of a limited number of

bacteria in colon, which promotes growth

Genomic Options

Growth Promotion & Disease Control

4-5 March 2015

Eliminate use of antimicrobials for growth promotion Reduce reliance on antimicrobials for disease control

Replacement breeding stock selected for fast and efficient growth Continue search for compounds that could (?) replace antibiotics

Immunity modulating agents, bacteriophages & lysins, phytodynamic

therapy (PDT), antimicrobial peptides (AMPs), pro-/pre-/synbiotics,

plant extracts, inhibitors targeting pathogenicity, feed enzymes, …

Improved infection control measures Promote vaccine use

13

Antimicrobial Growth Promotants

As intended, total antimicrobial use in livestock dropped.

But use of prescribed antimicrobials in livestock went up!

14

Cattle drug sales in Denmarksince 2001

Very High Importance High Importance Medium Importance0

10

20

30

40

50

60

70

2001200220032004200520062007200820092010

% o

f a

nti

mic

rob

ials

so

ld b

y

fee

dm

ills

an

d p

ha

rma

cie

s

Beef Value Chain Roundtable (Ottawa, Ontario)

15

Genomic Options

Treat INDIVIDUALS, not all

Adopt animal management practices and technologies that quickly identify sick individuals for closer inspection and treatment.

4-5 March 2015

Stop misuse and abuse of antimicrobials

Feed intake & behaviour monitoringPrecision Livestock Farming – “Virtual Shepherd”

AMR and Use in Canada

– A Federal Framework for Action

ACTION 3: Work with the animal agriculture

sector partners to strengthen the regulatory

framework on veterinary medicines and

medicated feeds, including facilitating

access to alternatives and encourage the

adoption of practices in order to reduce the

use of antimicrobials.

Track Temperature

Beef Value Chain Roundtable (Ottawa, Ontario)

16

Genomic Options

Miniaturized Equipment

4-5 March 2015

Point-of-need ID of microbes and treatment with correct antimicrobials

Methods of Identifying Microbes

(1) Biochemical

(2) Genetic tools (PCR, DNA fingerprinting)

(3) Spectral analysis (mass spectrometry, elastic light scattering,)

Laboratory Field

Miniaturize?

Point-of-need ID of microbes

E. coli

Beef Value Chain Roundtable (Ottawa, Ontario)

17

Nanocoatings• OxiTitan – mineral based photocatalyst solution applied to textiles and

surfaces has proven action against AMR bacteria ( C. Difficile 10x in 24h)• Nanoporous magnetic-like coating can trap and kill superbugs (S. aureus, )

Nanoparticles, nanosensors, nanocrystals, nanomechanical,• Accurate, economical, less time-consuming methods of detecting microbes• Targeted delivery of nanomedicines using bispecific antibodies

Nano-metals (Ag, Au, Fe, Cu) and metallic oxides (Ag2O, TiO2, ZnO, …)• Metal nanoparticles are effective against a broad spectrum of AMR bacteria

Nano-enabled antibiotics• A variety of nanosized carriers can be used as drug delivery systems

Genomic Options

Nano-based Solutions

4-5 March 2015

Preventive Measures / Diagnosis / Therapies

Beef Value Chain Roundtable (Ottawa, Ontario)

Genomic Options

DNA Barcoding

4-5 March 2015

18

Rapid ID of microbes and treatment with correct antimicrobials

Animal Groups Land Plants

matK(1500 bp)rbcL

CO1(648 bp)

Microbes

• Chaperonin-60 (cpn60)

• ?

DNA barcoding is a technique for characterizing species of organisms using a short DNA sequence from a standard and agreed-upon position in the genome. DNA barcode sequences are very short relative to the entire genome and they can be obtained reasonably quickly and cheaply.

Beef Value Chain Roundtable (Ottawa, Ontario)

19

Most antibiotics were discovered by screening cultivable soil microorganisms

PROBLEM SOLUTION

1% cultivable 99% NOT cultivable

iChip – isolate and grow uncultured bacteria in native soil

Genomic Options

Discover New Antibiotics

4-5 March 2015

End 30-year “discovery void”

50% cultivable

A New Antibiotic (Teixobactin) Kills

Pathogens Without Detectable Resistance

Ling, et. al. (2015)

NEW peptidoglycan synthesis inhibitor

Beef Value Chain Roundtable (Ottawa, Ontario)

20

Construct full-length cDNA of PEDV

Introduce attenuating mutations

Introduce strategic

DIVA mutations

Produce new vaccine

Genomic Options

New Vaccines / Therapeutics / Combinations

4-5 March 2015

Reduce reliance on antimicrobials and promote health

New Vaccines‘Smart Vaccines’ use reverse genomics to develop vaccines.

Porcine Epidemic Diarrhea Virus (PEDV)

~ VIDO-Intervac University of Saskatchewan

Therapeutics Investigate candidates that interrupt

bacterial protein synthesis or disrupt

bacterial cell wall

Alternatives to small molecule

antibiotics: monoclonal antibodies,

synthetic antibodies, small inhibitory

oligonucleotides, antibacterial peptides,

Combination Therapies Combination therapies that target both

essential functions and resistance

factors are also promising

Differentiate Infected from Vaccinated Animals

21

Genomic Options

Modern Tools for a Growing Challenge

4-5 March 2015Beef Value Chain Roundtable (Ottawa, Ontario)

Genomic technologies can be used…

To develop novel antibioticsMicrobial whole-genome sequencing (WGS) allows for rapid id of resistance mechanisms

For surveillanceMicrobial WGS provides insight into the history of emergence and spread of AMR

To study emergence of antibiotic resistance in real-time

To develop diagnostic tests and direct infection control measures

To study “Resistome” Predict evolution of resistance

Understand link between resistance and virulence

Defining novel targets which inactivation make bacteria more susceptible to antibiotics

22

Closing Remarks

4-5 March 2015Beef Value Chain Roundtable (Ottawa, Ontario)

Genomic Options Growth promotion and disease control

Treat INDIVIDUALS, not all

Miniaturized Equipment

Nano-based solutions

DNA barcoding

Discover new antibiotics

New vaccines / Therapeutics / Combinations

Modern tools for a Growing Challenge

Solutions to AMR will require new and creative ways of thinking, the integration of technologies and management

practices, and research investment dollars

Beef Value Chain Roundtable (Ottawa, Ontario)

23

Thank You

Acknowledgments

Susan Joyal – Consultant

Tim McAllister – AAFC

Reynold Bergen – BCRC

Cindy Bell – Genome Canada

4-5 March 2015